Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Diseases
100%
Dermatology
81%
Alopecia Areata
77%
Melanoma
69%
Contact Dermatitis
67%
Allergen
57%
Scalp
53%
Mohs Surgery
53%
Alopecia Mucinosa
50%
Patch Test
42%
Quality of Life
41%
Systematic Review
41%
Dermatitis
40%
Skin Cancer
37%
Skin Allergy
35%
Clinical Trial
34%
Dermatological Agent
33%
Neoplasm
32%
Biopsy Technique
32%
Dermatosis
31%
Oral
31%
Male Type Alopecia
31%
Cosmetics
28%
Hair Follicle
27%
Capillary Hemangioma
25%
Surgeon
25%
Mycosis fungoides
24%
Cross Sectional Study
24%
Tumor
23%
Clinician
23%
Epidermolysis bullosa
23%
Infection
22%
Squamous Cell Carcinoma
20%
Randomized Controlled Trial
20%
Pathogenesis
20%
Pediatrics
20%
Cancer
19%
Breast Cancer
19%
Scar Formation
19%
Hemangioma
18%
Pruritus
17%
Autoimmunity
17%
Contact Allergy
17%
Dermatomyositis
17%
Neck
17%
Acneiform Eruption
16%
Basal-Cell Carcinoma
16%
Teledermatology
16%
Cosmetic
16%
Retrospective Study
16%
Clinical Feature
15%
Histopathology
15%
Sunscreen
15%
Morbidity
15%
Wound Healing
15%
Adverse Event
15%
Immunofluorescence
14%
Vasculitis
14%
Prevalence
14%
Lymphedema
14%
Keratinocyte
14%
Wound
14%
Placebo
14%
Non Melanoma Skin Cancer
14%
Health Care Cost
13%
Rhinophyma
13%
Sun Exposure
13%
Papule
13%
Treatment Option
13%
Langerhans Cell
13%
Atopic Dermatitis
13%
Pathophysiology
13%
Malignant Neoplasm
13%
T Cell
12%
Low Level Laser Therapy
12%
Side Effect
12%
Erythema
12%
Bullous Pemphigoid
12%
Minoxidil
12%
Skin Biopsy
12%
Photograph
12%
Adolescence
12%
COVID-19
12%
Sunburn
11%
Vascular Anomaly
11%
Epidermolysis Bullosa Dystrophica
11%
Dermatoscopy
11%
Actinic Keratosis
11%
Skin Surgery
11%
Arm
11%
Inflammation
11%
Granuloma Annulare
11%
Photochemotherapy
10%
Venous Ulcer
10%
Surgery
10%
Thrombocyte Rich Plasma
10%
Congenital Malformation
10%
Pediatrics Patient
10%
Cutaneous T Cell Lymphoma
10%
Skin Manifestation
10%
Keyphrases
Alopecia Areata
99%
Patch Test
65%
North American Contact Dermatitis Group
63%
Allergen
51%
Allergic Contact Dermatitis
39%
United States
37%
Melanoma
36%
Hair Loss
33%
Mohs Micrographic Surgery
32%
Langerhans Cells
31%
Keratinocytes
31%
Dermatologist
31%
Patch Test Reactions
31%
Epidermis
31%
Retrospective Analysis
29%
Mycosis Fungoides
27%
Scalp
27%
Skin Cancer
26%
Contact Dermatitis
26%
Epidermolysis Bullosa
25%
Squamous Cell Carcinoma (SqCC)
24%
Human Keratinocytes (HaCaT)
24%
Atopic Dermatitis
23%
Clinical Trials
23%
Androgenetic Alopecia
23%
Quality of Life
23%
North America
22%
Positive Patch Tests
22%
Hair Follicle
21%
Psoriasis
21%
Infantile Hemangioma
20%
Tumor
19%
Inflammation
18%
T Cells
18%
Trichophyton Rubrum
18%
Dermatitis
17%
Alopecia
17%
95% Confidence Interval
17%
Formaldehyde
17%
Lymphedema
16%
Breast Cancer Survivors
15%
Randomized Controlled Trial
15%
Positive Reaction
15%
Dendritic Cells
15%
Contact Allergy
15%
Pruritus
15%
Risk Factors
14%
Bullous Pemphigoid
14%
Placebo
14%
Irritant
14%
Basal Cell Carcinoma
14%
Opioid Receptors
13%
Human Skin
13%
Wound Healing
13%
Bartonella Henselae
13%
Vasculitis
13%
Head-and-neck
13%
Mohs Surgery
13%
Opiate Receptors
13%
Immune Response
12%
Granuloma Annulare
12%
Female Pattern Hair Loss
12%
Indoor Tanning
12%
Allergic Reaction
12%
Clinical Features
12%
Finasteride
12%
Contact Hypersensitivity
12%
Cutaneous Squamous Cell Carcinoma (cSCC)
12%
Flap
12%
Allergy
11%
COVID-19
11%
Sun Protection Behaviors
11%
Topical Therapy
11%
Older Men
11%
Erythema
11%
Systemic Therapy
11%
Skin Diseases
10%
Blister
10%
Teledermatology
10%
Non-melanoma Skin Cancer
10%
Mannan
10%
Trunk
10%
Surgeons
10%
Photodynamic Therapy
10%
Histopathology
10%
Onychomycosis
10%
Rash
9%
Melanoma Survivors
9%
Immunology
9%
Polymorphonuclear Leukocytes
9%
Graft-versus-host Disease (GvHD)
9%
Sunburn
9%
Irritant Contact Dermatitis
9%
Autoimmune Disease
9%
Staphylococcus
9%
Health-related Quality of Life
9%
Corticosteroids
9%
Dermatology Residency Programs
9%
Odds Ratio
9%
Core Outcome Set
9%